Treatment of established colon carcinoma-bearing mice by dendritic cells pulsed with lysates of heat-treated tumor cells

Science in China, Series C: Life Sciences

Volumn 52, Issue 9, 2009, Pages 831-835

  Ying, Min Gang ^a   Zhen, Qiu Hong ^a   Liu, Sheng ^a   Gong, Fu Sheng ^a   Xie, Yun Qing ^a  

^a FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

Author keywords

Colon carcinoma; Dendritic cell; Heat treatment

Indexed keywords

TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; COLON TUMOR; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEAT; IMMUNOLOGY; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; COLONIC NEOPLASMS; DENDRITIC CELLS; HOT TEMPERATURE; IMMUNOTHERAPY, ADOPTIVE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 70350367729     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0112-6     Document Type: Article

References (15)

1. Gilboa E. DC-based cancer vaccines. J Chin Invest, 2007, 117: 1195-1203.
2. Scott E S, Stephen V, Ryan W, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res, 2002, 62: 1884-1889.
3. Jacques B, Beatrice S T, Karolina P, et al. Dendritic cells as vectors for therapy. Cell, 2001, 106: 271-274.
4. Todryk S M, Eaton J, Birchall L, et al. Heated tumour cells of autologous and allogeneic origin elicit anti-tumor immunity. Cancer Immunol Immunother, 2004, 3: 323-330.
5. Fu G Q, Meng F D, Guo R X, et al. Anti-tumor immune response induced by HSP70 (in Chinese). Cell Mol Immunol, 2002, 18: 393-396.
6. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med, 1992, 176: 1693-1702.
7. Kono K, Akahashi A, Sugai H, et al. Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Clin Cancer Res, 2002, 8: 3394-3400.
8. Rougier P, Andre T, Panis Y, et al. Colon cancer. Gastroenterol Clin Biol, 2006, 2: 2S24-2S29.
9. Saif M W. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer, 2006, 6: 46-51.
10. He X Z, Wang L, Zhang Y Y. An effective vaccine against colon cancer in mice: Use of recombinant adenovirus interleukin-12 transduced dendritic cells. World J Gastroenterol, 2008, 28:14: 532-540.
11. John M, Timmer M. Dendritic cell vaccines for cancer immunotherapy. Annual Review of Medicine, 1999, 50: 507-529.
12. Frank O, Nestle, Jacques B. Dendritic cells: On the move from bench to bedside. Nature Medicine, 2001, 7: 761-765.
13. Heiichiro U, Taketoshi Y. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol, 2001, 13: 1233-1242.
14. Massa C, Melani, C, Colombo M P. Chaperon and adjuvant activity of HSP70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res, 2005, 65: 7942-7949.
15. Stefan W, Krause, Robert G, et al. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells. Clin Cancer Res, 2004, 10: 3699-3707.